Protecting Kids from Pneumonia Hagerstown MD

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule) in Hagerstown.

VanDana Sajankila
(301) 790-3620
319 E Antietam St
Hagerstown, MD
Specialty
Pediatrics

Data Provided by:
Dr. Ruth A Dwyer
(301) 393-2600
1198 Kenly Ave Ste 100
Hagerstown, MD
Specialty
Pediatrics

Leon Douglas Weaver Jr, MD
(301) 393-2600
1198 Kenly Ave
Hagerstown, MD
Specialties
Pediatrics
Gender
Male
Education
Medical School: Howard Univ Coll Of Med, Washington Dc 20059
Graduation Year: 1998
Hospital
Hospital: Washington County Hospital, Hagerstown, Md
Group Practice: Antietam Pediatric & Adolscnt

Data Provided by:
Robinwood Medical Center - the Urological Center
(301) 733-0022
4040 Barranca Parkway Suite 200
Hagerstown, MD
 
Rohrer Suzann J Crnp
(301) 791-6666
324 East Antietam Street
Hagerstown, MD
 
Kristina Alma Athey, MD, FAAP
(301) 393-2600
1198 Kenly Ave
Hagerstown, MD
Specialties
Pediatrics
Gender
Male
Education
Graduation Year: 1992

Data Provided by:
The Audiology Center
(301) 739-0400
201 South Cleveland Avenue Suite 403
Hagerstown, MD
 
Dr. Angela Maria Tamayo
(616) 974-4889
101 King St
Hagerstown, MD
Specialty
Pediatrics

Dr. Eugene C Diokno
(301) 393-8686
319 E Antietam St
Hagerstown, MD
Specialty
Pediatrics

Bandy Bibhas C MD
(301) 733-1000
363 South Cleveland Avenue
Hagerstown, MD
 
Data Provided by:

Protecting Kids from Pneumonia

Provided By:

Parents and babies alike will be relieved by new findings that show a reduced-dose schedule for the pneumococcal vaccine can protect infants against pneumonia and other infections.

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule). But factors such as questions about the cost-effectiveness of the current PCV-7 dose schedule have led researchers to examine reduced-dose vaccine schedules, according to background information in the study.

The researchers, Dr. Elske J.M. van Gils, of the University Medical Center Utrecht in the Netherlands, and colleagues, studied 1,003 healthy infants who were randomly assigned to receive two doses of PCV-7 at 2 months and 4 months of age, or a 2 + 1-dose schedule at 2, 4 and 11 months of age, or no vaccine (control group). The children were checked after 12 months, 18 months and 24 months for pneumococcal microorganisms in the upper part of the throat behind the nose.

Compared to those in the control group, children in both vaccine groups had far lower rates of microorganisms that can cause pneumonia and other infections, according to the report in the July 8 issue of the Journal of the American Medical Association.

"In conclusion, both two-dose and 2 + 1-dose schedules of PCV-7 significantly reduce vaccine serotype pneumococcal carriage in children. This study supports future implementation of reduced-dose PCV-7 schedules," the researchers concluded.

More information

The Nemours Foundation has more about children and pneumonia.

SOURCE: Journal of the American Medical Association, news release, July 7, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com